Aperio Group LLC trimmed its position in Chemed Corp. (NYSE:CHE) by 3.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,051 shares of the company’s stock after selling 494 shares during the period. Aperio Group LLC owned 0.09% of Chemed Corp. worth $3,041,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in CHE. Teachers Advisors LLC boosted its holdings in Chemed Corp. by 3.0% in the 1st quarter. Teachers Advisors LLC now owns 30,431 shares of the company’s stock valued at $5,559,000 after purchasing an additional 894 shares during the period. State Street Corp boosted its holdings in Chemed Corp. by 9.1% in the 1st quarter. State Street Corp now owns 445,367 shares of the company’s stock valued at $81,370,000 after purchasing an additional 37,085 shares during the period. AQR Capital Management LLC boosted its holdings in Chemed Corp. by 10.6% in the 1st quarter. AQR Capital Management LLC now owns 16,514 shares of the company’s stock valued at $3,017,000 after purchasing an additional 1,576 shares during the period. Capstone Asset Management Co. boosted its holdings in Chemed Corp. by 2.7% in the 2nd quarter. Capstone Asset Management Co. now owns 1,857 shares of the company’s stock valued at $380,000 after purchasing an additional 49 shares during the period. Finally, Bank of Montreal Can boosted its holdings in Chemed Corp. by 2.4% in the 2nd quarter. Bank of Montreal Can now owns 3,311 shares of the company’s stock valued at $677,000 after purchasing an additional 77 shares during the period. 97.29% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This piece was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/11/12/aperio-group-llc-has-3-04-million-holdings-in-chemed-corp-che.html.
Shares of Chemed Corp. (NYSE CHE) opened at C$231.12 on Friday. Chemed Corp. has a fifty-two week low of C$143.87 and a fifty-two week high of C$235.96. The company has a current ratio of 0.50, a quick ratio of 0.48 and a debt-to-equity ratio of 0.15. The stock has a market cap of $3,690.06, a price-to-earnings ratio of 28.46, a PEG ratio of 4.89 and a beta of 1.14.
Chemed Corp. (NYSE:CHE) last posted its quarterly earnings data on Thursday, October 26th. The company reported C$2.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of C$2.00 by C$0.15. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.69%. The company had revenue of C$417.40 million during the quarter, compared to the consensus estimate of C$414.34 million. During the same period in the previous year, the firm posted $1.73 EPS. The firm’s revenue was up 6.3% compared to the same quarter last year. research analysts predict that Chemed Corp. will post 4.73 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 4th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date is Friday, November 10th. Chemed Corp.’s dividend payout ratio is currently 24.89%.
Several research analysts have commented on CHE shares. Zacks Investment Research downgraded shares of Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, September 13th. Oppenheimer Holdings, Inc. raised their price target on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Thursday, July 27th. TheStreet downgraded shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $209.00 price objective on shares of Chemed Corp. in a report on Friday, September 1st. Finally, KeyCorp initiated coverage on shares of Chemed Corp. in a report on Monday, August 28th. They set a “sector weight” rating for the company. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Chemed Corp. has a consensus rating of “Hold” and a consensus price target of C$236.00.
In related news, insider Spencer S. Lee sold 1,000 shares of Chemed Corp. stock in a transaction on Friday, September 1st. The shares were sold at an average price of C$197.46, for a total value of C$197,460.00. Following the transaction, the insider now owns 37,809 shares in the company, valued at approximately C$7,465,765.14. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 10,000 shares of Chemed Corp. stock in a transaction on Tuesday, October 31st. The stock was sold at an average price of C$223.42, for a total transaction of C$2,234,200.00. Following the completion of the transaction, the chief executive officer now owns 170,016 shares in the company, valued at approximately C$37,984,974.72. The disclosure for this sale can be found here. Insiders have sold a total of 15,650 shares of company stock valued at $3,480,193 over the last ninety days. 4.90% of the stock is currently owned by insiders.
Chemed Corp. Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.